NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research
Press Release NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research Natick, Massachusetts (November 6, 2024) – NeuroDex Inc. (“NeuroDex” or the “Company”) proudly announces its selection as a recipient of the Target ALS Biomarker Consortia Grant. This significant funding will bolster NeuroDex’s efforts to pioneer novel blood-based biomarkers, aiming to…